Valerie C. Besson
Paris, 75006, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Corrigendum to "Valproate, divalproex, valpromide: Are the differences in indications justified?" [Biomed. Pharmacother., 158 (2023) 114051].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 14, 2023
"Pharmacotrophy": a playful tournament for game- and team-based learning in pharmacology education - assessing its impact on students' performance.
Journal: BMC medical education
Published: August 05, 2023
Valproate, divalproex, valpromide: Are the differences in indications justified?
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 19, 2022
Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain.
Journal: Current issues in molecular biology
Published: April 22, 2021
Microglia and Neuroinflammation: What Place for P2RY12?
Journal: International journal of molecular sciences
Published: January 15, 2021
Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Journal: Fundamental & clinical pharmacology
Published: July 28, 2020
Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway.
Journal: International journal of molecular sciences
Published: July 28, 2020
Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress.
Journal: Neuroscience
Published: June 18, 2020
miR-146b Protects the Perinatal Brain against Microglia-Induced Hypomyelination.
Journal: Annals of neurology
Published: May 07, 2020
Histological and Behavioral Evaluation after Traumatic Brain Injury in Mice: A Ten Months Follow-Up Study.
Journal: Journal of neurotrauma
Published: December 14, 2019
Last Updated: 09/26/2026